Mercer Global Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
9,431
-902
| -9% | -$22K | ﹤0.01% | 1982 |
|
|
2025
Q1 | $215K | Sell |
10,333
-745
| -7% | -$15.5K | ﹤0.01% | 1933 |
|
|
2024
Q4 | $261K | Sell |
11,078
-3,649
| -25% | -$85.9K | ﹤0.01% | 1829 |
|
|
2024
Q3 | $358K | Sell |
14,727
-14,216
| -49% | -$345K | ﹤0.01% | 1530 |
|
|
2024
Q2 | $888K | Buy |
28,943
+26,053
| +901% | +$800K | ﹤0.01% | 1019 |
|
|
2024
Q1 | $453K | Buy |
+2,890
| New | +$453K | ﹤0.01% | 1332 |
|
|
2023
Q3 | – | Sell |
-7,856
| Closed | -$268K | – | 1955 |
|
|
2023
Q2 | $268K | Buy |
+7,856
| New | +$268K | ﹤0.01% | 1574 |
|
|
2023
Q1 | – | Sell |
-6,992
| Closed | -$207K | – | 1936 |
|
|
2022
Q4 | $207K | Sell |
6,992
-1,641
| -19% | -$48.6K | ﹤0.01% | 1696 |
|
|
2022
Q3 | $284K | Sell |
8,633
-3,623
| -30% | -$119K | ﹤0.01% | 1441 |
|
|
2022
Q2 | $386K | Sell |
12,256
-1,700
| -12% | -$53.5K | ﹤0.01% | 1291 |
|
|
2022
Q1 | $641K | Sell |
13,956
-204
| -1% | -$9.37K | ﹤0.01% | 1115 |
|
|
2021
Q4 | $867K | Sell |
14,160
-1,313
| -8% | -$80.4K | 0.01% | 947 |
|
|
2021
Q3 | $1.16M | Buy |
15,473
+10,356
| +202% | +$774K | 0.01% | 792 |
|
|
2021
Q2 | $473K | Buy |
5,117
+1,682
| +49% | +$155K | ﹤0.01% | 1168 |
|
|
2021
Q1 | $305K | Sell |
3,435
-30,598
| -90% | -$2.72M | ﹤0.01% | 1302 |
|
|
2020
Q4 | $3.17M | Sell |
34,033
-302
| -0.9% | -$28.2K | 0.04% | 309 |
|
|
2020
Q3 | $1.79M | Buy |
+34,335
| New | +$1.79M | 0.03% | 410 |
|
|
2020
Q2 | – | Sell |
-40,375
| Closed | -$1.26M | – | 1019 |
|
|
2020
Q1 | $1.26M | Buy |
+40,375
| New | +$1.26M | 0.03% | 413 |
|